New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 30, 2025 - Celltrion announced the FDA approval of Avtozma (tocilizumab-anoh), biosimilar to Genentech’s Actemra® (tocilizumab).
Download PDF
Return to publications
